# Female Heart Clinical Research Grants

**Funder:** Novo Nordisk Foundation
**Budget:** DKK 10M–15M per grant (total pool up to DKK 75M)
**Duration:** 3–5 years
**Consortium:** Required — main applicant at Nordic institution; at least one co-applicant outside main applicant's country
**Application:** 2-stage: Phase 1 concept note → Phase 2 full application with external peer review
**Eligible countries:** DK, SE, NO, FI, IS
**Official call:** https://novonordiskfonden.dk/en/grant/female-heart-clinical-research-grants/
**Last verified:** 20 June 2026

## Eligibility & scope

Main applicant must be an established researcher at a university, hospital, or non-profit research institution in a Nordic country (DK, SE, NO, FI, IS) with guaranteed salary for the full project period. At least one co-applicant must be based outside the main applicant's country. Co-applicants may be worldwide. Clinical research focus on female heart disease.

## Summary

The Novo Nordisk Foundation Female Heart Clinical Research Grants fund clinical research on female heart disease, offering DKK 10-15 million per project over 3-5 years across the Nordic region. The main applicant must be an established researcher at a Nordic university, hospital, or non-profit institution with guaranteed salary; at least one co-applicant must be based outside the applicant's home country (worldwide eligible). This is a two-stage call: Phase 1 concept note followed by Phase 2 full application with external peer review.

## Who should apply

- Established researchers with guaranteed salary at Nordic universities, hospitals, or non-profit research institutions
- Main applicants based in Denmark, Sweden, Norway, Finland, or Iceland
- Researchers leading multidisciplinary or multinational teams in clinical female heart disease research
- Consortia with at least one co-applicant from outside the main applicant's country

## Key dates

- Phase 1 concept note deadline to be announced
- Applicants notified in April regarding Phase 2 invitation
- Project duration 3-5 years

## Tips for applicants

- International co-applicant partnerships are gating, ensure your co-applicant is confirmed and committed before submission; this funder treats consortium quality as an evaluation criterion.
- Female heart disease focus is tight: ground your clinical research question in sex-specific cardiac pathology or outcomes to align with the funder's strategic priority.
- Guarantee of salary for the full project period must be documented; budget for this explicitly and confirm with your institution's finance office in advance.

## Frequently asked questions

### How much does the Novo Nordisk Foundation Female Heart Clinical Research Grant fund?

DKK 10-15 million per project, with a total pool of up to DKK 75 million available.

### Who is eligible to apply for the Female Heart Clinical Research Grant?

Established researchers at Nordic universities, hospitals, or non-profit institutions in Denmark, Sweden, Norway, Finland, or Iceland with guaranteed salary for the full project period.

### Is a consortium required for the Female Heart Clinical Research Grant?

Yes, at least one co-applicant must be based outside the main applicant's country; co-applicants may be based worldwide.

### What is the project duration for the Female Heart Clinical Research Grant?

Projects run for 3-5 years.

### How does the application process work?

The call is two-stage: Phase 1 concept note, followed by Phase 2 full application with external peer review for invited applicants.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/novo-nordisk-foundation-female-heart-clinical-research-grants-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.